Grant, J., Bourcier, K., Wallace, S. S., Pan, D., Conway, A., Seyfert-Margolis, V., and Wallace, P. K. Validated Protocol for FoxP3 Reveals Increased Expression in Type 1 Diabetes Patients. Cytometry B Clin Cytom, 76B: 67-157, 2009.
Wallace, P. K., Tario Jr., J. D., Fisher, J. L., Wallace, S. S., Ernstoff, M. S., and Muirhead, K. A. Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution. Cytometry A, 73: 1019-34, 2008.
Wood, B. L., Arroz, M., Barnett, D., DiGuiseppe, J., Greig, B., Kussick, S. J., Oldaker, T., Shenkin, M., Stone, E., and Wallace, P. K. 2006 Bethesda international consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom, 72 Suppl 1: S14-22, 2007.
Bercovici, N., Givan, A. L., Waugh, M. G., Fisher, J. L., Vernel-Pauillac, F., Ernstoff, M. S., Abastado, J. P., and Wallace, P. K. Multiparameter precursor analysis of T-cell responses to antigen. J Immunol Methods, 276: 5-17, 2003.
Wallace, P. K., Romet-Lemonne, J. L., Chokri, M., Fanger, M. W., and Fadul, C. E. Production of macrophage activated killer cells for in vivo targeting to glioblastoma with a bispecific antibody to FcgRI and EGF receptor. Cancer Immunol Immunother, 49: 493-503, 2000.
Wallace, P. K., Keler, T., Coleman, K., Fisher, J. L., Vitale, L. A., Graziano, R. F., Guyre, P. M., and Fanger, M. W. Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgRI), blocks phagocytosis, and modulates receptor expression. J Leukoc Biol, 62: 469-79, 1997.
[Grant, 2009 #133]
[Wallace, 2008 #134]
[Wood, 2007 #119]
[Bercovici, 2003 #71]
[Wallace, 2000 #30]
[Wallace, 1997 #14]
[Wallace, 1993 #8]